Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AQST
#2919
Aquestive Therapeutics, Inc. Common Stock
4.1
5
USD
-0.95%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.95%
Monthly Change
+2.98%
6 month change
-40.37%
Year Change
+64.68%
Previous Close
4.1
9
Open
4.1
5
Bid
Ask
Low
4.1
5
High
4.1
5
Volume
79
Markets
US Stock Market
Healthcare
AQST
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
36.21 M
41.47 M
55.87 M
73.3 M
98.87 M
122.05 M
—
Valuation ratios
Enterprise value
198.84 M
214.88 M
102.43 M
198.14 M
402.46 M
838.38 M
2.03 B
Price to earnings ratio
—
-2.1
-0.8
-15.46
-6.98
-8.28
-26.06
Price to sales ratio
—
2.91
0.92
2.43
5.36
15.51
39.86
Price to cash flow ratio
—
-4.49
-4.48
-19.3
-8.63
-13.17
-35.8
Price to book ratio
—
-1.8
-0.37
-1.16
-5.13
-20.52
-25.78
Enterprise value to EBITDA ratio
-5.89
-7.71
-2.71
-16.76
-20.81
-14.09
-44.61
Profitability ratios
Return on assets %
-0.89
-1.14
-0.95
-0.14
-0.44
-0.52
-0.66
Return on equity %
1.15
0.86
0.46
0.07
0.73
2.49
5.27
Return on invested capital %
-977.37
—
—
—
—
—
—
Gross margin %
71.72
100
100
58.82
68.95
58.35
232.5
Operating margin %
-93.55
-68.22
-88.23
-29.86
-53.46
-159.5
-646.94
EBITDA margin %
-80.4
-55.05
-82.77
-23.37
-33.6
-133.59
-540.27
Net margin %
-121.67
-138.77
-114.11
-15.56
-76.68
-188.09
-763.8
Liquidity ratios
Quick ratio
2
1.97
0.86
1.87
4.36
3.01
16.29
Current ratio
2.11
2.15
1.01
2.24
4.68
3.14
17.47
Inventory turnover
4.87
—
—
3.32
2.79
3.04
2.54
Asset turnover
0.65
0.81
0.8
0.88
0.72
0.34
0.37
Solvency ratios
Debt to assets ratio
0.59
0.86
0.91
0.88
0.5
0.31
1.65
Debt to equity ratio
-0.76
-0.65
-0.44
-0.48
-0.84
-1.48
-15.2
Long term debt to total assets ratio
0.82
0.83
0.9
0.78
0.44
0.28
1.48
Long term debt to total equity ratio
-1.06
-0.63
-0.43
-0.42
-0.75
-1.34
-13.65
Per share metrics
Operating cash flow per share
—
-0.87
-0.2
-0.1
-0.41
-0.49
-0.52
EBIT per share
—
-0.91
-0.86
-0.25
-0.35
-0.66
-0.69
EBITDA per share
—
-0.73
-0.81
-0.19
-0.22
-0.56
-0.58
Total debt per share
—
1.41
1.07
0.83
0.58
0.47
1.95
Cash per share
—
—
—
—
—
—
—
Net current asset value per share
—
1.24
0.82
0.67
1.02
1.4
4.52
Tangible book value per share
—
-2.16
-2.46
-1.76
-0.69
-0.31
-1.72
Working capital per share
—
0.66
0.01
0.37
0.8
0.95
3.42
Book value per share
—
-2.16
-2.43
-1.74
-0.69
-0.31
-1.72
News
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Aquestive Therapeutics: Post-CRL Risk, Timeline, And Valuation (NASDAQ:AQST)
Aquestive Therapeutics chief people officer Boyd sells $124k in stock
Aquestive Therapeutics CEO Barber sells $753,965 in stock
Aquestive Therapeutics SVP Cioffi sells $105k in shares
Aquestive therapeutics chief legal officer Braender sells $167k in stock
Aquestive Therapeutics: With Some Hiccups, Anaphylm Is Closer To FDA Approval
Aquestive at Leerink Conference: Strategic Focus on Anaphylm
Citizens reiterates Aquestive stock rating on clear FDA path
Aquestive Therapeutics, Inc. (AQST) Q4 2025 Earnings Call Transcript
Aquestive Q4 2025 slides detail FDA setback, resubmission plan
Compared to Estimates, Aquestive Therapeutics (AQST) Q4 Earnings: A Look at Key Metrics